As a medical student, Chelsea Peterson, DO, had a rotation in the leukemia service at Roswell Park Comprehensive Cancer Center.
“I loved it. I loved the innovation and the research opportunities that were available here as well as the culture,” she says.
Now, as a member of the Transplant and Cellular Therapy team at Roswell Park, she’s eager to see the continued evolution of cellular and CAR T-cell therapies for patients beyond just those with solid tumors.
“We’re going to see it moving into earlier lines of therapy, instead of just third-line options, we’re going to see it in a first-line setting,” both for patients with solid tumors but liquid tumors, something the researchers at Roswell Park are already working to advance.
Additionally, Dr. Peterson will continue her research on lymphoma treatments, including a focus on “adoptive cell therapy and the different ways we can use it in all sorts of lymphomas as well as the ways we can make it more accessible, more affordable, and hopefully limit the toxicities associated with it.”
BROADCASTMED